Sustained Treatment Effect of Spinal Cord Stimulation in Painful Diabetic Peripheral Neuropathy: 24-Month Follow-up of a Prospective Two-Center Randomized Controlled Trial

Autor: Nicolaas C. Schaper, Rachel Slangen, Alfons G. H. Kessels, Maarten van Kleef, Catharina G. Faber, Elbert A.J. Joosten, Carmen D. Dirksen, Robert van Dongen, Maarten van Beek
Přispěvatelé: Anesthesiology, EMGO - Musculoskeletal health, Interne Geneeskunde, MUMC+: KIO Kemta (9), Epidemiologie, Anesthesiologie, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: MHeNs - R3 - Neuroscience, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Klinische Neurowetenschappen
Rok vydání: 2015
Předmět:
Zdroj: Beek, M, Slangen, R, Schaper, N C, Faber, C G, Joosten, E A, Dirksen, C D, van Dongen, R T, Kessels, A G H & van Kleef, M 2015, ' Sustained Treatment Effect of Spinal Cord Stimulation in Painful Diabetic Peripheral Neuropathy: 24-Month Follow-up of a Prospective Two-Center Randomized Controlled Trial ', Diabetes Care, vol. 38, no. 9, pp. E132-E134 . https://doi.org/10.2337/dc15-0740
Diabetes Care, 38(9), E132-E134. American Diabetes Association Inc.
Diabetes Care, 38(9), e132-e134. American Diabetes Association
Diabetes Care, 38, 9, pp. e132-4
Diabetes Care, 38, e132-4
ISSN: 0149-5992
DOI: 10.2337/dc15-0740
Popis: Spinal cord stimulation (SCS) has been demonstrated to serve as a successful second-line treatment modality for painful diabetic peripheral neuropathy (PDPN), as documented in two randomized clinical trials (RCTs) (1,2). Besides the fact that these two RCTs demonstrate a pain-relieving effect for a period of 6 months after the start of SCS treatment, only small observational studies suggest a long-term sustained effect in PDPN (3–5). In this article, we present the 24-month follow-up data of our recently published RCT in Diabetes Care (1). Thirty-six patients were enrolled in this study, and after randomization, 22 patients with PDPN in the lower limbs (15 male, mean age 57.1 years [SD 12.4], years of PDPN 6.0 [SD 5.1]) were assigned to the SCS group. A 2-week trial stimulation was performed to evaluate sufficient pain relief. After 6 …
Databáze: OpenAIRE